12-6526331-A-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_014865.4(NCAPD2):c.2526A>T(p.Glu842Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD2 | NM_014865.4 | c.2526A>T | p.Glu842Asp | missense_variant | 20/32 | ENST00000315579.10 | NP_055680.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD2 | ENST00000315579.10 | c.2526A>T | p.Glu842Asp | missense_variant | 20/32 | 1 | NM_014865.4 | ENSP00000325017 | P1 | |
NCAPD2 | ENST00000382457.8 | c.2142A>T | p.Glu714Asp | missense_variant | 17/21 | 5 | ENSP00000371895 | |||
NCAPD2 | ENST00000542492.1 | n.459A>T | non_coding_transcript_exon_variant | 4/8 | 5 | |||||
NCAPD2 | ENST00000539084.5 | c.*2221A>T | 3_prime_UTR_variant, NMD_transcript_variant | 19/31 | 2 | ENSP00000438495 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251494Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135922
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461894Hom.: 0 Cov.: 42 AF XY: 0.0000509 AC XY: 37AN XY: 727248
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.2526A>T (p.E842D) alteration is located in exon 20 (coding exon 19) of the NCAPD2 gene. This alteration results from a A to T substitution at nucleotide position 2526, causing the glutamic acid (E) at amino acid position 842 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at